Publications & Works

Published journal articles indexed by SCI, SSCI, and AHCI

Hematopoietic Adverse Events Associated with BNT162b2 mRNA Covid-19 Vaccine

UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI, vol.32, no.1, pp.65-67, 2022 (Peer-Reviewed Journal) Sustainable Development identifier identifier

Could Targeting HMGB1 be Useful for the Clinical Management of COVID-19 Infection?

COMBINATORIAL CHEMISTRY & HIGH THROUGHPUT SCREENING, vol.24, no.4, pp.587-590, 2021 (Peer-Reviewed Journal) Sustainable Development identifier identifier identifier

Protein Kinases in Hematological Disorders

PROTEIN KINASE-MEDIATED DECISIONS BETWEEN LIFE AND DEATH, vol.1275, pp.383-393, 2021 (Peer-Reviewed Journal) Sustainable Development identifier identifier

Covid-19 scientific publications from Turkey

TURKISH JOURNAL OF MEDICAL SCIENCES, vol.51, no.3, pp.877-889, 2021 (Peer-Reviewed Journal) Sustainable Development identifier identifier identifier

Antiinfective and wound-healing pleiotropic actions of Ankaferd hemostat

TURKISH JOURNAL OF MEDICAL SCIENCES, vol.50, no.5, pp.1434-1435, 2020 (Peer-Reviewed Journal) identifier identifier identifier

Local Bone Marrow Renin-Angiotensin System and COVID-19

UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI, vol.30, no.2, pp.113-120, 2020 (Peer-Reviewed Journal) Sustainable Development identifier identifier

WHO 2016 Definition of Chronic Myeloid Leukemia and Tyrosine Kinase Inhibitors

TURKISH JOURNAL OF HEMATOLOGY, vol.37, no.1, pp.42-47, 2020 (Peer-Reviewed Journal) Sustainable Development identifier identifier identifier

COVID-19, Renin-Angiotensin System, and Hematopoiesis

TURKISH JOURNAL OF HEMATOLOGY, vol.37, no.3, pp.207-208, 2020 (Peer-Reviewed Journal) Sustainable Development identifier identifier identifier

Ankaferd Hemostat Affects Etoposide Resistance of the Malignant Melanoma Cells

UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI, vol.30, no.1, pp.43-53, 2020 (Peer-Reviewed Journal) Sustainable Development identifier identifier

Current perspectives for the treatment of chronic myeloid leukemia

TURKISH JOURNAL OF MEDICAL SCIENCES, vol.49, no.1, pp.1-10, 2019 (Peer-Reviewed Journal) identifier identifier identifier

The impact of JAK/STAT inhibitor ruxolitinib on the genesis of lymphoproliferative diseases

TURKISH JOURNAL OF MEDICAL SCIENCES, vol.49, no.2, pp.661-674, 2019 (Peer-Reviewed Journal) identifier identifier identifier

On Being a "Physician Patient" with His Own Experimental Therapeutic Drug

TURKISH JOURNAL OF HEMATOLOGY, vol.35, no.4, pp.302-303, 2018 (Peer-Reviewed Journal) identifier identifier identifier

Lipotoxicity-Related Hematological Disorders in Obesity

OBESITY AND LIPOTOXICITY, vol.960, pp.469-487, 2017 (Peer-Reviewed Journal) identifier identifier

A myelofibrosis case that develops mycobacterial infection after ruxolitinib treatment

INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, vol.10, no.4, pp.7304-7307, 2017 (Peer-Reviewed Journal) Sustainable Development identifier identifier

Splenic artery embolization with Ankaferd blood stopper in a sheep model

DIAGNOSTIC AND INTERVENTIONAL RADIOLOGY, vol.22, no.4, pp.354-357, 2016 (Peer-Reviewed Journal) identifier identifier identifier

Dasatinib-Induced Severe Hemorrhagic Colitis in Chronic Myeloid Leukemia

UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI, vol.26, no.1, pp.67-68, 2016 (Peer-Reviewed Journal) identifier identifier

A CML case with resistant pleural effusion with tyrosine kinase inhibitor treatment

INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, vol.9, no.7, pp.14884-14887, 2016 (Peer-Reviewed Journal) identifier identifier

Idelalisib at the Crossroads of B-Cell Lymphoproliferative Disorders

UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI, vol.26, no.1, pp.12-19, 2016 (Peer-Reviewed Journal) identifier identifier

Comparison of Myelodysplastic Syndrome Prognostic Scoring Systems

TURKISH JOURNAL OF HEMATOLOGY, vol.33, no.2, pp.119-126, 2016 (Peer-Reviewed Journal) identifier identifier identifier

A Bing-Neel syndrome case

INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, vol.9, no.11, pp.22660-22663, 2016 (Peer-Reviewed Journal) identifier identifier

Molecular Management of Chronic Lymphocytic Leukemia: Towards a Chemotherapy-Free Approach

UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI, vol.26, no.1, pp.1-11, 2016 (Peer-Reviewed Journal) identifier identifier

The factors affecting early death after the initial therapy of acute myeloid leukemia

INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, vol.8, no.12, pp.22564-22569, 2015 (Peer-Reviewed Journal) identifier identifier

Tryptophan in Molecular Hematopoiesis

TRYPTOPHAN METABOLISM: IMPLICATIONS FOR BIOLOGICAL PROCESSES, HEALTH AND DISEASE, pp.253-267, 2015 (Peer-Reviewed Journal) identifier

Clinicopathological associations of acquired erythroblastopenia

INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, vol.8, no.12, pp.22515-22519, 2015 (Peer-Reviewed Journal) identifier identifier

Clinical Perspectives About the Molecular Management of B-Lymphoproliferative Neoplasms

UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI, vol.24, no.3, pp.1-3, 2014 (Peer-Reviewed Journal) identifier

As a Rare Presentation of Waldenstrom's Macroglobulinemia; Fever

UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI, vol.24, no.3, pp.221-222, 2014 (Peer-Reviewed Journal) identifier identifier

Ibrutinib: From Molecule to Medicine

UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI, vol.24, no.3, pp.4-14, 2014 (Peer-Reviewed Journal) Sustainable Development identifier

Turkish Chronic Myeloid Leukemia Study: Retrospective Sectional Analysis of CML Patients

TURKISH JOURNAL OF HEMATOLOGY, vol.30, no.4, pp.351-358, 2013 (Peer-Reviewed Journal) identifier

Short-Term Effects of Ankaferd Hemostat for Renal Artery Embolization: An Experimental Study

CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY, vol.36, no.2, pp.498-504, 2013 (Peer-Reviewed Journal) identifier identifier identifier

Oral High-Dose Ankaferd Administration Effects on Gastrointestinal System

INTERNATIONAL JOURNAL OF MEDICAL SCIENCES, vol.10, no.4, pp.451-456, 2013 (Peer-Reviewed Journal) identifier identifier identifier

Renin-Angiotensin System (RAS) Expressions in Myeloid Leukemic Cell Lines

UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI, vol.23, no.4, pp.264-268, 2013 (Peer-Reviewed Journal) identifier identifier

Striking Promotion of the In Vitro Myeloma Monoclonal Immunoglobulin Aggregation by Ankaferd Hemostat

UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI, vol.22, no.1, pp.15-22, 2012 (Peer-Reviewed Journal) identifier identifier

The Clinical Impact of Low Doses of Dasatinib in Patients with Chronic Myeloid Leukemia

UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI, vol.22, no.1, pp.8-14, 2012 (Peer-Reviewed Journal) identifier

Increased ACE in extrahepatic cholangiocarcinoma as a clue for activated RAS in biliary neoplasms

CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY, vol.35, no.10, pp.644-649, 2011 (Peer-Reviewed Journal) identifier identifier identifier

Ankaferd hemostat for the management of tumoral GI bleeding

GASTROINTESTINAL ENDOSCOPY, vol.73, no.5, pp.1072-1073, 2011 (Peer-Reviewed Journal) identifier identifier identifier

EVALUATION OF A HAEMOSTATIC AGENT IN RABBITS

AFRICAN JOURNAL OF TRADITIONAL COMPLEMENTARY AND ALTERNATIVE MEDICINES, vol.8, no.1, pp.61-65, 2011 (Peer-Reviewed Journal) Sustainable Development identifier identifier identifier

Pathobiological aspects of the local bone marrow renin-angiotensin system: a review

JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM, vol.11, no.4, pp.205-213, 2010 (Peer-Reviewed Journal) Sustainable Development identifier identifier identifier

Ankaferd Blood Stopper for Gastrointestinal Bleeding

JOURNAL OF INVESTIGATIVE SURGERY, vol.23, no.4, pp.239, 2010 (Peer-Reviewed Journal) identifier identifier identifier

Prognostic Factors Affecting the Clinical Course of non-Hodgkin's Lymphomas

UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI, vol.20, no.2, pp.96-102, 2010 (Peer-Reviewed Journal) identifier identifier

Functional proteomic analysis of Ankaferd (R) Blood Stopper

TURKISH JOURNAL OF HEMATOLOGY, vol.27, no.2, pp.70-77, 2010 (Peer-Reviewed Journal) identifier identifier

Safety and Efficacy of Ankaferd Blood Stopper in Dental Surgery

UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI, vol.20, no.1, pp.1-5, 2010 (Peer-Reviewed Journal) identifier identifier

In Vitro Anti-Bacterial Activities of Ankaferd Medicinal Plant Extract

TURKIYE KLINIKLERI TIP BILIMLERI DERGISI, vol.29, no.2, pp.410-415, 2009 (Peer-Reviewed Journal) identifier identifier

Haemostatic actions of the folkloric medicinal plant extract Ankaferd Blood Stopper Response

JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, vol.36, no.6, pp.1448-1449, 2008 (Peer-Reviewed Journal) identifier

Change in Blood Coagulation Parameters After Total Body Irradiation

UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI, vol.18, no.3, pp.135-140, 2008 (Peer-Reviewed Journal) identifier identifier

Soluble platelet glycoprotein V in distinct disease states of pathological thrombopoiesis

JOURNAL OF THE NATIONAL MEDICAL ASSOCIATION, vol.100, no.1, pp.86-90, 2008 (Peer-Reviewed Journal) identifier identifier identifier

Rethinking leptin and insulin action: Therapeutic opportunities for diabetes

INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, vol.38, pp.820-830, 2006 (Peer-Reviewed Journal) Sustainable Development identifier identifier identifier

Overt gastrointestinal bleeding in haematologic neoplasms

DIGESTIVE AND LIVER DISEASE, vol.37, no.12, pp.917-922, 2005 (Peer-Reviewed Journal) identifier identifier identifier

Current debates in antiphospholipid syndrome: The acquired antibody-mediated thrombophilia

CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, vol.10, no.2, pp.89-126, 2004 (Peer-Reviewed Journal) identifier identifier identifier

Protein C inhibitor and serum amyloid A in immune thrombocytopaenic purpura

JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, vol.32, no.1, pp.62-65, 2004 (Peer-Reviewed Journal) identifier identifier identifier

Decreased protein Z concentrations complicating the hypercoagulable state of Behcet's disease

CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, vol.9, no.3, pp.259-263, 2003 (Peer-Reviewed Journal) identifier identifier identifier

Towards the understanding of the local hematopoietic bone marrow renin-angiotensin system

INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, vol.35, no.6, pp.867-880, 2003 (Peer-Reviewed Journal) Sustainable Development identifier identifier identifier

Pathologic thrombopoiesis of rheumatoid arthritis

RHEUMATOLOGY INTERNATIONAL, vol.23, no.2, pp.49-60, 2003 (Peer-Reviewed Journal) identifier identifier identifier

Global fibrinolytic capacity is decreased in polycystic ovary syndrome, suggesting a prothrombotic state

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, vol.87, no.8, pp.3871-3875, 2002 (Peer-Reviewed Journal) Sustainable Development identifier identifier

Hemostatic parameters in Behcet's disease: a reappraisal

RHEUMATOLOGY INTERNATIONAL, vol.22, no.1, pp.9-15, 2002 (Peer-Reviewed Journal) identifier identifier identifier

Plasma thrombospondin in immune thrombocytopenic purpura

JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, vol.30, no.1, pp.52-55, 2002 (Peer-Reviewed Journal) Sustainable Development identifier identifier identifier

Aplastic pancytopenia associated with thymoma

ANNALS OF HEMATOLOGY, vol.79, no.11, pp.648-650, 2000 (Peer-Reviewed Journal) identifier

Behcet's disease.

NEW ENGLAND JOURNAL OF MEDICINE, vol.342, no.8, pp.588, 2000 (Peer-Reviewed Journal) identifier

Selectin adhesion molecules in Behcet's disease

ANNALS OF THE RHEUMATIC DISEASES, vol.59, no.1, pp.61-63, 2000 (Peer-Reviewed Journal) identifier

Articles Published in Other Journals

Effects of Smoking on Hematological Parameters and Ferritin Levels

HASEKI TIP BULTENI-MEDICAL BULLETIN OF HASEKI, vol.57, no.4, pp.372-376, 2019 (Peer-Reviewed Journal) Sustainable Development identifier identifier

Farklı Trombositopeni Sebeplerinin Klinik ve Laboratuvar Bulguları

Journal of Contemporary Medicine, vol.7, no.4, pp.316-322, 2017 (Peer-Reviewed Journal)

Monitoring the Response to Tyrosine Kinase Inhibitor (TKI) Treatment in Chronic Myeloid Leukemia (CML)

MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES, vol.6, no.1, 2014 (Peer-Reviewed Journal) identifier identifier

THE FACTORS INFLUENCING OVERALL SURVIVAL IN NEWLY DIAGNOSED ADULT ACUTE LYMPHOBLASTIC LEUKEMIA PATIENTS

JOURNAL OF ISTANBUL FACULTY OF MEDICINE-ISTANBUL TIP FAKULTESI DERGISI, vol.74, no.1, pp.7-12, 2011 (Peer-Reviewed Journal) identifier

Refereed Congress / Symposium Publications in Proceedings

Long-Term Results of Non-Fludarabine Versus Fludarabine-Based Conditioning Regimens in Severe Aplastic Anemia Patients

60th Annual Meeting of the American-Society-of-Hematology (ASH), California, United States Of America, 1 - 04 December 2018, vol.132 identifier

Descriptive analysis of myeloproliferative diseases and its complications

9th International Eurasian Hematology Oncology Congress (EHOC), İstanbul, Turkey, 17 - 20 October 2018, vol.73 identifier

Donor Lymphocyte Infusions: Single Center Experience

LYMPHOMAMYELOMA 2017, New York, United States Of America, 26 - 28 November 2017, vol.1, pp.48

Amyloidosis Induced Abnormal coagulopathy associated with multible coagulation Factor Deficiencies.

XXVI. Congress of the international society on Thrombosis and Haemostasis, Berlin, Germany, 08 July 2017 - 13 January 2018, vol.1, pp.402

Determination of chemoterapoetic drug sensitivity subgroups of acute leukemia

41st FEBS Congress on Molecular and Systems Biology for a Better Life, Kusadasi, Turkey, 3 - 08 September 2016, vol.283, pp.373-374 identifier

AN IGD MYELOMA CASE THAT IS RESISTANT TO CARFILZOMIB

6th International Eurasian Hematology Congress, Antalya, Turkey, 14 - 18 October 2015, vol.39 identifier

A COMPOSITE LYMPHOMA CASE

6th International Eurasian Hematology Congress, Antalya, Turkey, 14 - 18 October 2015, vol.39 identifier

BLEOMYCIN-INDUCED INTERSTITIAL LUNG DISEASE: A CASE REPORT

6th International Eurasian Hematology Congress, Antalya, Turkey, 14 - 18 October 2015, vol.39 identifier

A PLASMA CELL LEUKEMIA CASE

6th International Eurasian Hematology Congress, Antalya, Turkey, 14 - 18 October 2015, vol.39 identifier

GENERIC IMATINIB MESYLATE IS AS EFFECTIVE AS ORIGINAL GLIVEC IN THE MANAGEMENT OF CML

20th Congress of the European Hematology Association Vienna, Austria June 11-14,2015, 11 - 14 June 2014

Haemostatic actions of the folkloric medicinal plant extract, Ankaferd Blood Stopper

49th Annual Meeting of the American-Society-of-Hematology, Georgia, United States Of America, 8 - 11 December 2007, vol.110 identifier

Over-expression of the local bone marrow renin-angiotensin system in acute myeloid leukemia.

47th Annual Meeting of the American-Society-of-Hematology, Georgia, United States Of America, 10 - 13 December 2005, vol.106 identifier

Levels of the circulating leukemia inhibitory factor in patients with vasculitis

Annual European Congress of Rheumatology, Lisbon, Portugal, 18 June 2003, vol.62, pp.447-448 identifier

Thrombopoietin levels in the pulmonary vessels in patients with and without pulmonary hypertension.

44th Annual Meeting of the American-Society-of-Hematology, PHILADELPHIA, PENNSYLVANIA, 6 - 10 December 2002, vol.100 identifier

Books & Book Chapters